ST-segment elevation in patients with COVID-19: a systematic review

Pharmacology, Toxicology and Pharmaceutical Science

• Cardiovascular Disease 16%
• Clinical Feature 16%
• Coronary Artery Disease 100%
• Coronavirinae 100%
• Disease 100%
• Hospital Mortality 16%
• Myocarditis 16%
• ST Segment Elevation Myocardial Infarction 33%
• Stent Thrombosis 16%
• Symptom 16%
• Takotsubo Cardiomyopathy 16%
• Thorax Pain 16%

Keyphrases

• Coronary Angiography 20%
• Coronary Stent 20%
• Feature Management 20%
• Left Ventricular Wall Motion Abnormality 20%
• Mimickers 20%
• Non-obstructive Coronary Artery Disease 40%
• Obstructive Coronary Artery Disease 80%
• ST-segment Elevation 100%
• Takotsubo Cardiomyopathy 20%

Medicine and Dentistry

• Coronary Angiography 16%
• Fibrinolysis 16%
• Myocarditis 16%
• Primary Percutaneous Coronary Intervention 16%